Health Condition 1: null- All Retinobloastoma patients who were offered/received treatment of any type (i.e. focal therapy, surgery, chemotherapy, radiotherapy, palliative approach (i.e. no intervention)).
Conditions
Interventions
None listed
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Participating center: in which treatment-naïve Rb patients are seen and treated by any means. There is no lower or upper limit to the number of Rb patients seen in a center in order for it to become a participating center in the study. We are aiming to reach out and include as many Rb centers from around the world. Subjects: All Rb patients that presented to a participating center from 01/01/2017-31/12/2017 and were offered/received treatment of any type (i.e. focal therapy, surgery, chemotherapy, radiotherapy, palliative approach (i.e. no intervention)).
Exclusion criteria
Exclusion criteria: Patients that presented following primary treatment given/offered elsewhere.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To report on the presentation mode of children diagnosed with Rb throughout the world, during 2017, with special attention to intra- versus extraocular disease presentation. Timepoint: 01/01/2017-31/12/2017 data to be collected | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
Argentina, Armenia, Australia, Bangladesh, Benin, Brazil, Burundi, Canada, Chile, China, Cote d'Ivoire, Czech Republic, Democratic Republic of the Congo, Denmark, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Germany, Haiti, Honduras, Hungary, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Italy, Jamaica, Japan, Jordan, Kenya, Kyrgyzstan, Latvia, Lebanon, Lithuania, Malawi, Malaysia, Mali, Mexico, Morocco, Myanmar, Nepal, Netherlands, Nigeria, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Republic of Korea, Russian Federation, Saudi Arabia, Singapore, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Swaziland, Sweden, Switzerland, Thailand, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uzbekistan, Viet Nam, Yemen, Zambia, Zimbabwe
Contacts
Public ContactTushar Vora
Tata Memorial Hospital
Outcome results
None listed